Literature DB >> 18093505

[Therapy compliance in cases of hyperlipaemia, as measured through electronic monitors. Is a reminder calendar to avoid forgetfulness effective?].

Emilio Márquez Contreras1, José Joaquín Casado Martínez, Juan Motero Carrasco, José Luis Martín de Pablos, Rosa Chaves González, Carmen Losada Ruiz, José Carlos Pastoriza Vilas.   

Abstract

OBJECTIVE: To analyse the efficacy of the intervention with a calendar reminder of the medication taking in the treatment of the hyperlipidemias.
DESIGN: Controlled, randomised clinical trial.
SETTING: Twelve clinics at 5 primary care centres, Spain. PARTICIPANTS: Two hundred and twenty people diagnosed with hypercholesterolaemia according to Spanish Consensus criteria were chosen. INTERVENTION: Two groups were formed. The control group (CG) of 110 patients, who received the doctor's normal treatment; and the Intervention group (IG) of 110 patients, who received in addition a calendar remider of medication taking. MAIN MEASUREMENTS: Meausured of compliance was performed by moniotrs electronic (MEMS) and cholesterol, triglycerides, HDL-C, and LDL-C determined at the start, and at the third and sixth months. Percentages of patients complying (80%-110%), the mean compliance percentage and the degree of control were compared. The reduction of absolute and relative risk (RAR and RRR) and the mean number of people that required an intervention in order to avoid non-compliance (NI) were calculated.
RESULTS: One hundred and eighty eight people (85.45%) completed the survey, 96 in the IG and 92 in the CG; 26.55% were non compliers with the therapy (CI, +/-6.3%) (IG, 10.5%, CI, +/-4.6%; CG, 42.6%, CI, +/-10.1% [P<.0001]). Mean compliance ran at 88,1% (IC, +/-4.6%) overall, at 92% (CI, +/-5.4%) in the IG and at 84% (CI, +/-7.4%) in the IG (P<.05). The RAR was 32.1%, the RRR 75.35%, and the NI was 3.1 patients. The patients with cholesterol controlled ran at 66.7% (CI, +/-9.4%) in the IG and 41.2% in the CG (P<.001).
CONCLUSIONS: The calendar reminder intervention is an efficacious way of improving the percentage of patients complying with lipaemia treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18093505     DOI: 10.1157/13113960

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  9 in total

1.  [One more tool to improve therapeutic compliance].

Authors:  Carme Batalla Martínez
Journal:  Aten Primaria       Date:  2009-03-25       Impact factor: 1.137

2.  [Levothyroxine therapy compliance. What can we do to improve it?].

Authors:  Rosa López-Torres Hidalgo; Jose Antonio Carbajal de Lara
Journal:  Aten Primaria       Date:  2012-04-30       Impact factor: 1.137

3.  [Therapeutic non-compliance with insulin in the treatment of diabetes mellitus 2].

Authors:  Emilio Márquez Contreras; Nieves Martell Claros; Vicente Gil Guillén; José Joaquín Casado Martínez; José Luis Martín de Pablos; Javier Ferraro García; Rosa Chaves González; Amalia Fernández Ortega
Journal:  Aten Primaria       Date:  2011-10-22       Impact factor: 1.137

Review 4.  Interventions to improve adherence to lipid-lowering medication.

Authors:  Mieke L van Driel; Michael D Morledge; Robin Ulep; Johnathon P Shaffer; Philippa Davies; Richard Deichmann
Journal:  Cochrane Database Syst Rev       Date:  2016-12-21

Review 5.  Interventions for enhancing medication adherence.

Authors:  Robby Nieuwlaat; Nancy Wilczynski; Tamara Navarro; Nicholas Hobson; Rebecca Jeffery; Arun Keepanasseril; Thomas Agoritsas; Niraj Mistry; Alfonso Iorio; Susan Jack; Bhairavi Sivaramalingam; Emma Iserman; Reem A Mustafa; Dawn Jedraszewski; Chris Cotoi; R Brian Haynes
Journal:  Cochrane Database Syst Rev       Date:  2014-11-20

Review 6.  A Metaanalysis of Interventions to Improve Adherence to Lipid-Lowering Medication.

Authors:  Richard E Deichmann; Michael D Morledge; Robin Ulep; Johnathon P Shaffer; Philippa Davies; Mieke L van Driel
Journal:  Ochsner J       Date:  2016

Review 7.  Improving medication adherence in hypercholesterolemia: challenges and solutions.

Authors:  Justin Gatwood; James E Bailey
Journal:  Vasc Health Risk Manag       Date:  2014-11-06

Review 8.  Inclusion of People with Disabilities in Research to Improve Medication Adherence: A Systematic Review.

Authors:  Jaclyn K Schwartz; Elizabeth Unni
Journal:  Patient Prefer Adherence       Date:  2021-07-26       Impact factor: 2.711

9.  Is the physician's behavior in dyslipidemia diagnosis in accordance with guidelines? Cross-sectional ESCARVAL study.

Authors:  Antonio Palazón-Bru; Vicente F Gil-Guillén; Domingo Orozco-Beltrán; Vicente Pallarés-Carratalá; Francisco Valls-Roca; Carlos Sanchís-Domenech; José M Martín-Moreno; Josep Redón; Jorge Navarro-Pérez; Antonio Fernández-Giménez; Ana M Pérez-Navarro; José L Trillo; Ruth Usó; Elías Ruiz
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.